About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Docs on Twitter


Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Washington Legal Foundation "Conversations With" Series Examines IP Issues | Main | C5 Pharma & Biotech Collaborative Agreements Conference »

November 14, 2008

Icon Acquires Prevalere

    By Jason Derry --

Icon Icon plc has announced its acquisition of Prevalere Life Sciences Inc., a move that will expand Icon's bioanalytics and immunoassay business in the United States.  Prevalere, identified in the announcement as a wholly owned subsidiary of ORS Labs Inc, is a New York-based contract research organization that provides consulting and testing services for biotechnology and pharmaceutical companies.  Icon is a European-based contract research organization that also provides clinical trial services for clients in the biotechnology and pharmaceutical industries, as well as the medical device industry.  Icon has agreed to acquire Prevalere for an upfront payment of $35 million, and up to $8.2 million in milestone payments.

Prevalere Life Sciences Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 10:11 PM in Biotech/Pharma Business |

Comments

The comments to this entry are closed.

March 2023

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Categories

Archives

More...